Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Saul Centers to Market Perform

Raymond James Downgrades Saul Centers to Market Perform

Raymond James analyst RJ Milligan downgrades Saul Centers (NYSE:BFS) from Outperform to Market Perform.

byBenzinga Newsdesk

January 4, 2023

1 minute read

Raymond James analyst RJ Milligan downgrades Saul Centers (NYSE:BFS) from Outperform to Market Perform.

Setback For Novo Nordisk? Denmark Shifts Prescription Guidelines, Favoring Cost-Effective Alternatives For Ozempic

By Benzinga Neuro

May 1, 10:44 AM

The agency noted that in 2023, half of the new type 2 diabetes patients started their treatment with a reimbursed GLP-1 drug without trying a cheaper alternative first.

NVO

Analyst Ratings

6 Analysts Have This to Say About Synchrony Finl

By Benzinga Insights

July 11, 12:11 PM

Synchrony Finl (NYSE:SYF) has observed the following analyst ratings within the last quarter:

SYF

Analyst Ratings

Where Royal Caribbean Gr Stands With Analysts

By Benzinga Insights

September 19, 5:00 PM

Within the last quarter, Royal Caribbean Gr (NYSE:RCL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

RCL

Why SoundHound AI, BigBear.Ai Shares Are Rising After Hours

By Adam Eckert

March 2, 5:55 PM

SoundHound AI Inc (NASDAQ: SOUN) and BigBear.Ai Inc (NYSE: BBAI) shares are moving higher in extended trading Thursday after C3.Ai Inc (NYSE:

Raymond James Downgrades Saul Centers to Market Perform

Related Posts

Setback For Novo Nordisk? Denmark Shifts Prescription Guidelines, Favoring Cost-Effective Alternatives For Ozempic

6 Analysts Have This to Say About Synchrony Finl

Where Royal Caribbean Gr Stands With Analysts

Why SoundHound AI, BigBear.Ai Shares Are Rising After Hours